Henry Meds Monthly vs Prepaid Plans: Which Option Costs Less?

Last reviewed: September 15, 2026 Last updated: September 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Henry Meds' prepaid plans deliver meaningful per-month savings over its own month-to-month pricing—injectable semaglutide drops from $297/month to $197/month on a 12-month prepaid commitment—but require full upfront payment and lock you into a term with limited cancellation flexibility. Whether a Henry prepaid plan is the most cost-effective choice depends on the medication and how it compares to flexible month-to-month alternatives: PlexusDx charges $189/month for injectable semaglutide with no commitment and $149/month on a six-month plan ($894 upfront), delivering a lower 12-month total than Henry's comparable tiers. For oral semaglutide, Henry's prepaid plans undercut PlexusDx's month-to-month rate. The economic case for any prepaid plan rests on your willingness to prepay, tolerance for dose or medication changes mid-term, and confidence in 6–12 months of uninterrupted treatment.

At-a-glance comparison: Henry Meds vs PlexusDx

Henry Meds pricing verified July 20, 2026 and September 4, 2026; PlexusDx pricing verified July 20, 2026. Henry Meds rating captured from public Trustpilot profile; PlexusDx rating captured September 9, 2026 (trustpilot.com/review/plexusdx.com).

Henry Meds monthly vs prepaid pricing: all tiers

Henry Meds structures its pricing around three plan lengths—month-to-month, six-month prepaid, and twelve-month prepaid—with per-month rates declining as commitment increases. Every tier is all-inclusive: medication, provider visits, supplies, and shipping are bundled with no separate membership fee (henrymeds.com, verified July 20, 2026 and September 4, 2026).

Injectable compounded semaglutide

• Month-to-month: $297/month
• Six-month prepaid: $247/month—$1,482 paid in full upfront
• Twelve-month prepaid: $197/month—$2,364 paid in full upfront

The 12-month plan represents a $100/month discount against the month-to-month rate, or $1,200 in total annual savings within Henry's own pricing ladder.

Sublingual (oral) semaglutide tablets

• Month-to-month: $249/month
• Six-month prepaid: $169/month—$1,014 paid in full upfront
• Twelve-month prepaid: $149/month—$1,788 paid in full upfront

Injectable compounded liraglutide

• Month-to-month: $179/month
• Six-month prepaid: $149/month—$894 paid in full upfront
• Twelve-month prepaid: $119/month—$1,428 paid in full upfront

Oral tirzepatide and oral semaglutide three-month plans

Henry Meds also offers three-month prepaid options for oral tirzepatide ($297/month, $891 upfront) and oral semaglutide ($179/month, $537 upfront). However, the September 4, 2026 source capture flagged internal inconsistencies: the oral tirzepatide page displays both a $891 total and a $1,047 standard total and states delivery "every 60 days for 6 months"; the oral semaglutide page shows both $537 and $747 totals and incorrectly references tirzepatide in explanatory copy. We recommend confirming the exact total, supply duration, and billing cadence at checkout before committing to either three-month plan.

Normalized 12-month costs: month-to-month and prepaid

To compare month-to-month flexibility against prepaid savings, we calculated total out-of-pocket cost over 12 months for each tier, renewing prepaid commitments as needed. All figures below are our calculations from verified per-month or upfront rates.

Injectable semaglutide: Henry Meds

• Month-to-month: 12 × $297 = $3,564/year
• Six-month prepaid (renewed twice): 2 × $1,482 = $2,964/year
• Twelve-month prepaid: $2,364/year

Within Henry's own pricing, the 12-month prepaid plan saves $1,200 per year against month-to-month.

Oral semaglutide: Henry Meds

• Month-to-month: 12 × $249 = $2,988/year
• Six-month prepaid (renewed twice): 2 × $1,014 = $2,028/year
• Twelve-month prepaid: $1,788/year

Injectable semaglutide: PlexusDx

• Month-to-month: 12 × $189 = $2,268/year
• Three-month plan (renewed four times): 4 × $507 = $2,028/year (prepaid per quarter; our calculation)
• Six-month plan (renewed twice): 2 × $894 = $1,788/year (prepaid per half-year; our calculation)

Oral semaglutide: PlexusDx

• Month-to-month: 12 × $289 = $3,468/year
• PlexusDx does not offer multi-month pricing for oral semaglutide.

Like-for-like comparison: injectable semaglutide

Comparing matching commitment lengths for injectable compounded semaglutide:

All 12-month totals are our calculations from verified per-month or upfront rates.

On both month-to-month and six-month comparisons, PlexusDx delivers a lower annual cost. Henry's 12-month prepaid plan ($2,364) has no direct PlexusDx equivalent; PlexusDx's longest commitment is six months.

Like-for-like comparison: oral semaglutide

Henry Meds holds the oral-semaglutide cost advantage at every tier, saving $480 per year on month-to-month and offering six- and twelve-month prepaid options PlexusDx does not match for oral formulations.

What prepayment gets you—and what it costs

Prepaid plans lower the effective monthly rate in exchange for upfront capital and reduced flexibility. Key trade-offs:

• Upfront cash requirement: Henry's 12-month injectable semaglutide plan requires $2,364 at enrollment; the six-month plan requires $1,482. PlexusDx's six-month injectable plan requires $894.
• Cancellation and refunds: Henry Meds permits cancellation of month-to-month plans anytime via patient portal, email (ask@henrymeds.com), or phone (909-787-2342). Canceling a prepaid multi-month plan may require paying out the remaining balance unless the provider determines medical reasons justify early exit (henrymeds.com, verified September 15, 2026). PlexusDx month-to-month plans cancel anytime; multi-month plans are committed-term purchases.
• Dose or medication changes mid-term: If a provider adjusts your dose or switches medications during a prepaid commitment, you remain obligated for the full prepaid amount. Month-to-month plans adapt immediately without sunk cost.
• Supply shortage or pharmacy switches: Compounded GLP-1 availability fluctuates. A prepaid plan does not guarantee uninterrupted supply if your pharmacy experiences a shortage or regulatory change.

Decision factors beyond per-month rate

Medication and route options

Henry Meds offers compounded semaglutide (injectable and sublingual), liraglutide (injectable), and oral tirzepatide. It does not offer injectable tirzepatide (henrymeds.com, verified July 20, 2026). PlexusDx offers injectable semaglutide, injectable tirzepatide, and oral semaglutide and tirzepatide, plus a microdose injectable GLP-1 protocol at $129/month.

Dose progression and same-price-at-every-dose policies

PlexusDx charges the same monthly rate regardless of dose: a patient at 0.25 mg semaglutide pays $189/month, and a patient titrated to 2.4 mg pays $189/month (plexusdx.com, verified July 20, 2026). Henry Meds' pricing structure does not explicitly state whether higher doses carry surcharges; confirm dose-independent pricing at intake if you anticipate titration.

Pharmacy type

Henry Meds works with 503A compounding pharmacies or outsourcing facilities (henrymeds.com, verified September 15, 2026). PlexusDx works exclusively with licensed 503A compounding pharmacies. Both pharmacy types produce compounded medications that are not FDA-approved; FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Delivery timeline and cadence

Henry Meds ships medication 8–10 business days after the provider consultation, with refills arriving every 45 days for injectables and every 90 days for oral tablets; California residents may experience longer fulfillment times (henrymeds.com, verified September 15, 2026). PlexusDx delivery timelines are determined by the partner pharmacy and vary by state and medication.

Age eligibility

Henry Meds serves patients ages 18–70 (henrymeds.com, verified September 15, 2026). PlexusDx eligibility is determined by the licensed provider at intake and does not publish a hard age ceiling.

Choose Henry Meds if…

• You prefer oral semaglutide and want the lowest 12-month cost available in this comparison: $1,788 prepaid beats PlexusDx's $3,468 month-to-month oral rate by $1,680.
• You are confident in 12 months of continuous treatment, can prepay the full year upfront, and want Henry's $197/month injectable semaglutide rate—the lowest per-month figure for injectable semaglutide in this analysis.
• You want injectable liraglutide, which PlexusDx does not offer.
• You are comfortable with outsourcing facilities in addition to 503A pharmacies.

Choose PlexusDx if…

• You want the flexibility of true month-to-month pricing with the lowest ongoing rate: $189/month for injectable semaglutide with no contract saves $1,296/year against Henry's $297 month-to-month.
• You prefer a shorter prepaid commitment—PlexusDx's six-month injectable semaglutide plan ($894 upfront, $1,788 annualized) costs $1,176 less per year than Henry's comparable six-month tier and matches Henry's 12-month oral semaglutide total.
• You want injectable tirzepatide, which Henry does not offer.
• You value same-price-at-every-dose predictability or want access to a microdose GLP-1 protocol for maintenance or initial cautious titration.
• You want the option to add medication-response testing ($99 for program members) with a complimentary pharmacist consultation, though the test does not select or predict medication—your provider makes that determination.

Methodology and freshness

Henry Meds pricing verified from henrymeds.com on July 20, 2026 and September 4, 2026. PlexusDx pricing verified from plexusdx.com on July 20, 2026. Review ratings: Henry Meds captured from public Trustpilot profile; PlexusDx 4.3-star rating (79% five-star, 83% four stars or higher) verified September 9, 2026 at trustpilot.com/review/plexusdx.com. All 12-month cost totals, annualized prepaid equivalents, and savings figures are our calculations from verified per-month or upfront rates. Internal source conflicts on Henry's oral tirzepatide and oral semaglutide three-month plans (alternate totals, plan-duration inconsistencies) are documented in the text with an explicit recommendation to confirm at checkout. We do not guarantee eligibility, medication selection, dose, or uninterrupted supply; a licensed provider makes all clinical determinations.

Frequently Asked Questions

Does Henry Meds refund prepaid plans if I need to stop treatment early?

Henry Meds may require you to pay out the remaining balance of a prepaid multi-month plan unless your provider determines that medical reasons justify early cancellation. Month-to-month plans cancel anytime without penalty via the patient portal, email, or phone.

Can I switch from month-to-month to a prepaid plan mid-treatment?

Henry Meds and PlexusDx both allow plan changes, but the mechanics and timing vary by provider. Contact Henry at ask@henrymeds.com or 909-787-2342, or reach PlexusDx support, to confirm whether you can convert an active month-to-month subscription into a prepaid commitment and whether any credit applies.

What happens if my dose increases during a prepaid plan?

If your provider raises your dose mid-term, confirm whether the prepaid rate remains fixed or whether a surcharge applies. PlexusDx explicitly charges the same monthly rate at every dose; Henry Meds' dose-change policy should be confirmed at intake or when your provider adjusts your prescription.

Are compounded semaglutide and tirzepatide FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Neither Henry Meds nor PlexusDx may claim compounded drugs are the same as branded Wegovy, Ozempic, Saxenda, Mounjaro, or Zepbound.

Which prepaid plan offers the absolute lowest 12-month cost for injectable semaglutide?

PlexusDx's six-month injectable semaglutide plan renewed twice totals $1,788 per year (our calculation: 2 × $894). Henry Meds' 12-month prepaid plan totals $2,364. PlexusDx saves $576 annually, though Henry's plan requires only one upfront payment versus two six-month prepayments with PlexusDx.

Sources

• Henry Meds pricing and plan details: henrymeds.com (verified July 20, 2026 and September 4, 2026)
• Henry Meds cancellation, delivery, and eligibility: henrymeds.com (captured September 15, 2026)
• PlexusDx pricing, same-price-at-every-dose policy, and medication-response testing: plexusdx.com (verified July 20, 2026)
• PlexusDx Trustpilot rating: trustpilot.com/review/plexusdx.com (captured September 9, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.